Ann Shue, MD
Ophthalmology · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 17
- 3 carriers
- Offices
- 3
Offices
3 locations · Stanford Health Care · Lpch Medical Group Div of Lucile
Looking this up.
Hospitals listed: Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
17 plans · 3 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Shue’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
17 of 17 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A162511 · Current
Licensed to practise in California · since 2019 · expires 2027-05-31 · University of California, Irvine College of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$20,840
Medicare paid this office $20,840 for 82 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Short return visit (20+ min) | 51 | $3,765 | $57 |
| Return visit (30+ min) | 25 | $2,695 | $90 |
| Long return visit (40+ min) | 14 | $1,880 | $118 |
| Exam of visual field with extended testing | 37 | $1,246 | $24 |
| Imaging of optic nerve | 50 | $1,129 | $19 |
See all 8 services
| Short return visit (20+ min) | 51 | $3,765 | $57 |
| Return visit (30+ min) | 25 | $2,695 | $90 |
| Long return visit (40+ min) | 14 | $1,880 | $118 |
| Exam of visual field with extended testing | 37 | $1,246 | $24 |
| Imaging of optic nerve | 50 | $1,129 | $19 |
| Exam to measure eye deviation and range of motion | 22 | $1,000 | $33 |
| Exam of the internal drainage system of eye | 38 | $728 | $18 |
| Ultrasound scan of cornea to determine thickness | 13 | $92 | $7 |
Procedures Medicare counted
| Cataract surgery | 22 | More than 46% of doctors who do this |
Who their Medicare patients are
82 Original Medicare patients in 2024. Average age 73 · Under 65 15% · 85 and older 13% · Women 55% · Also on Medicaid 29% · Health risk score 1.42. Above the middle of the specialty; the typical ophthalmology clinician is at 1.16.
Conditions among them: High blood pressure 66% · Diabetes 34% · Chronic kidney disease 24% · Cancer 17% · Coronary heart disease 16% · Atrial fibrillation 16% · Heart failure 15%.
The office billed $103,722, Medicare allowed $27,169 and paid $20,840; for 368 services of 31 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 82 | 368 | 73 | 1.42 | $103,722 | $20,840 |
| 2023 | 80 | 386 | 71 | 1.26 | $222,385 | $33,367 |
| 2022 | 77 | 436 | 73 | 1.32 | $168,786 | $31,006 |
| 2021 | 57 | 330 | 71 | 1.55 | $92,771 | $21,612 |
| 2020 | 40 | 254 | 69 | 1.05 | $148,594 | $21,105 |
| 2019 | 23 | 62 | 70 | 1.52 | $57,562 | $7,472 |
| 2018 | 30 | 37 | 66 | 2.66 | $10,919 | $1,645 |
| 2017 | 35 | 42 | 71 | 2.30 | $15,491 | $2,602 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 8 services
| Return visit (30+ min) | 31 | $3,707 | $77 |
| Long return visit (40+ min) | 17 | $2,975 | $129 |
| Short return visit (20+ min) | 39 | $2,745 | $53 |
| Exam of visual field with extended testing | 44 | $1,259 | $22 |
| Imaging of optic nerve | 43 | $960 | $19 |
| Exam of the internal drainage system of eye | 29 | $479 | $16 |
| Imaging of retina | 12 | $327 | $22 |
| Ultrasound scan of cornea to determine thickness | 14 | $86 | $6 |
2022: 8 services
| Return visit (30+ min) | 38 | $5,309 | $79 |
| Long return visit (40+ min) | 19 | $2,905 | $116 |
| Short return visit (20+ min) | 29 | $2,655 | $55 |
| Exam of visual field with extended testing | 43 | $1,442 | $22 |
| Imaging of optic nerve | 41 | $1,043 | $19 |
| Exam of the internal drainage system of eye | 28 | $517 | $16 |
| Photography of the retina | 19 | $393 | $20 |
| Imaging of front third of eye | 12 | $212 | $15 |
2021: 7 services
| Return visit (30+ min) | 30 | $5,939 | $80 |
| Long return visit (40+ min) | 15 | $2,766 | $120 |
| Exam of visual field with extended testing | 28 | $1,147 | $23 |
| Imaging of optic nerve | 32 | $783 | $19 |
| Exam of the internal drainage system of eye | 24 | $449 | $18 |
| Photography of the retina | 14 | $270 | $19 |
| Ultrasound scan of cornea to determine thickness | 20 | $150 | $7 |
2020: 5 services
| Return visit (30+ min) | 29 | $3,686 | $66 |
| New patient visit (45+ min) | 13 | $1,167 | $90 |
| Short return visit (20+ min) | 13 | $1,035 | $45 |
| Exam of visual field with extended testing | 14 | $633 | $25 |
| Imaging of optic nerve | 24 | $530 | $20 |
2017: 1 service
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 12 | $397 | $33 |
Medicaid work
$3,729 in 2024
Medicaid paid $3,729 for 40 billed services this clinician did in 2024, up to 13 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Short return visit (20+ min) | 40 | $3,729 |
| 2024 | 40 | 1 | 13 | $3,729 |
| 2023 | 386 | 6 | 34 | $24,284 |
| 2022 | 305 | 5 | 24 | $23,605 |
| 2021 | 333 | 6 | 21 | $27,129 |
| 2020 | 174 | 1 | 29 | $14,013 |
| 2019 | 39 | 2 | 12 | $2,674 |
| 2018 | 12 | 1 | 12 | $981 |
See the largest Medicaid services in earlier years
2023
| Short return visit (20+ min) | 168 | $11,147 |
| Return visit (30+ min) | 69 | $6,774 |
| FUNDUS PHOTOGRAPHY W/INTERPRETATION & REPORT | 94 | $4,613 |
| GONIOSCOPY | 27 | $708 |
| Visual field examination, unilateral or bilateral, with interpretation and report; extended examination (eg, Goldmann visual fields with at least 3 isopters plotted and static determination within the central 30°, or quantitative, automated threshold perimetry, Octopus program G-1, 32 or 42, Humphrey visual field analyzer full threshold programs 30-2, 24-2, or 30/60-2) | 13 | $603 |
| Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; optic nerve | 15 | $439 |
2022
| Return visit (30+ min) | 106 | $10,883 |
| Short return visit (20+ min) | 153 | $9,129 |
| Long return visit (40+ min) | 15 | $2,372 |
| FUNDUS PHOTOGRAPHY W/INTERPRETATION & REPORT | 17 | $845 |
| GONIOSCOPY | 14 | $377 |
2021
| Return visit (30+ min) | 210 | $19,877 |
| FUNDUS PHOTOGRAPHY W/INTERPRETATION & REPORT | 56 | $2,950 |
| Long return visit (40+ min) | 13 | $1,957 |
| Short return visit (20+ min) | 30 | $1,201 |
| Visual field examination, unilateral or bilateral, with interpretation and report; extended examination (eg, Goldmann visual fields with at least 3 isopters plotted and static determination within the central 30°, or quantitative, automated threshold perimetry, Octopus program G-1, 32 or 42, Humphrey visual field analyzer full threshold programs 30-2, 24-2, or 30/60-2) | 12 | $606 |
| Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; optic nerve | 12 | $538 |
2020
| Return visit (30+ min) | 174 | $14,013 |
2019
| Return visit (30+ min) | 26 | $1,850 |
| OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST | 13 | $825 |
2018
| Return visit (30+ min) | 12 | $981 |
Drugs they prescribed that Part D paid
$7,972
Pharmacies billed $7,972 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 157) in 2024. At or below the middle of the specialty; the typical ophthalmology clinician is at 0%.
119 generic and 38 brand-name prescriptions · $7,972 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Brimonidine | 11 | $538 | $49 |
| Latanoprost | 31 | $251 | $8 |
| Erythromycin | 15 | $203 | $14 |
| Timolol Maleate | 22 | $71 | $3 |
Year by year
| 2024 | 157 | 39 | 0% (0) | 24% | $7,972 |
| 2023 | 358 | 53 | 0% (0) | 37% | $46,741 |
| 2022 | 333 | 46 | None | 35% | $42,317 |
| 2021 | 239 | 30 | 0% (0) | 38% | $25,853 |
| 2020 | 144 | 32 | None | 40% | $12,225 |
| 2019 | 147 | 51 | None | 54% | $20,965 |
| 2018 | 351 | 118 | None | 53% | $41,003 |
| 2017 | 140 | 79 | 0% (0) | 49% | $11,572 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 14 drugs
| Lumigan | 19 | $9,405 | $495 |
| Rhopressa | 15 | $5,825 | $388 |
| Alphagan P | 11 | $5,072 | $461 |
| Brimonidine | 27 | $3,534 | $131 |
| Methazolamide | 13 | $2,772 | $213 |
| Fluorometholone | 12 | $858 | $72 |
| Prednisolone Acetate | 25 | $841 | $34 |
| Dorzolamide-Timolol | 20 | $531 | $27 |
| Latanoprost | 28 | $455 | $16 |
| Doxycycline Hyclate | 18 | $450 | $25 |
| Moxifloxacin | 13 | $386 | $30 |
| Timolol Maleate | 29 | $367 | $13 |
| Erythromycin | 25 | $302 | $12 |
| Ketorolac Tromethamine | 13 | $215 | $17 |
2022: 12 drugs
| Alphagan P | 11 | $4,819 | $438 |
| Rhopressa | 12 | $4,495 | $375 |
| Methazolamide | 16 | $4,309 | $269 |
| Travoprost | 15 | $2,552 | $170 |
| Brimonidine | 27 | $1,876 | $69 |
| Moxifloxacin | 26 | $734 | $28 |
| Latanoprost | 32 | $459 | $14 |
| Prednisolone Acetate | 15 | $436 | $29 |
| Dorzolamide-Timolol | 13 | $371 | $29 |
| Ketorolac Tromethamine | 13 | $324 | $25 |
| Timolol Maleate | 18 | $186 | $10 |
| Erythromycin | 14 | $161 | $11 |
2021: 7 drugs
| Rhopressa | 16 | $4,946 | $309 |
| Dorzolamide-Timolol | 15 | $942 | $63 |
| Brimonidine | 30 | $768 | $26 |
| Prednisolone Acetate | 17 | $746 | $44 |
| Dorzolamide | 15 | $468 | $31 |
| Latanoprost | 26 | $455 | $18 |
| Erythromycin | 16 | $224 | $14 |
2020: 5 drugs
| Prednisolone Acetate | 18 | $764 | $42 |
| Brimonidine | 13 | $638 | $49 |
| Ketorolac Tromethamine | 11 | $369 | $34 |
| Latanoprost | 13 | $325 | $25 |
| Timolol Maleate | 22 | $204 | $9 |
2019: 3 drugs
| Brimonidine | 20 | $1,942 | $97 |
| Prednisolone Acetate | 13 | $491 | $38 |
| Latanoprost | 13 | $274 | $21 |
2018: 10 drugs
| Combigan | 34 | $10,639 | $313 |
| Alphagan P | 24 | $6,970 | $290 |
| Azopt | 13 | $5,130 | $395 |
| Travatan Z | 12 | $3,058 | $255 |
| Latanoprost | 93 | $1,807 | $19 |
| Brimonidine | 13 | $927 | $71 |
| Prednisolone Acetate | 20 | $569 | $28 |
| Dorzolamide-Timolol | 25 | $527 | $21 |
| Timolol Maleate | 25 | $303 | $12 |
| Dorzolamide | 11 | $232 | $21 |
2017: 3 drugs
| Prednisolone Acetate | 17 | $862 | $51 |
| Latanoprost | 31 | $583 | $19 |
| Dorzolamide-Timolol | 11 | $343 | $31 |
Money from drug and device companies
$78 in 2025
| 2025 | 1 | 2 | None | $78 |
| 2024 | 4 | 5 | None | $396 |
| 2023 | 4 | 4 | None | $246 |
| 2022 | 3 | 4 | None | $214 |
| 2021 | 1 | 1 | None | $25 |
| 2020 | 2 | 2 | None | $109 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Alcon Vision | Hydrus Microstent | $78 | 2 payments
|
See all 2 published payments
| Alcon Vision | Meals · 2025-10-14 | Precision 1 | $26 |
| Alcon Vision | Meals · 2025-09-17 | Hydrus Microstent | $52 |
See earlier years (2024, 2023, 2022, 2021, 2020)
2024: $396
| Alcon Vision | Hydrus Microstent | $210 | 2 payments
|
| Glaukos | Istent Trabecular Micro-Bypass System Model Is3 | $93 | 1 payment
|
| Sight Sciences | Omni Surgical System | $68 | 1 payment
|
| Johnson & Johnson Surgical Vision | Tecnis Simplicity | $24 | 1 payment
|
2023: $246
| AbbVie | Xen Glaucoma Treatment System | $83 | 1 payment
|
| Apellis Pharmaceuticals | Syfovre | $74 | 1 payment
|
| Alcon Vision | Hydrus Microstent | $45 | 1 payment
|
| Sight Sciences | Omni Surgical System | $45 | 1 payment
|
2022: $214
| Sight Sciences | Omni(R) Surgical System (US) | $119 | 2 payments
|
| Alcon Vision | Acrysof Iq Panoptix Uv Iol | $51 | 1 payment
|
| Johnson & Johnson Surgical Vision | Tecnis Iol | $43 | 1 payment
|
2021: $25
| Sight Sciences | Omni(R) Surgical System (US) | $25 | 1 payment
|
2020: $109
| Allergan | None | $60 | 1 payment
|
| Sight Sciences | Omni | $49 | 1 payment
|
Professional record
- NPI
- 1184967796
- Licence
- CA A162511, CT 56473, NC 2018-00675California A162511: Current · expires 2027-05-31
- Trained
- University of California, Irvine, California College of Medicine, 2013
- Group
- Stanford Health Care · Lpch Medical Group Div of Lucile
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207WX0110X (207WX0110X); Federal specialty code 207W00000X (207W00000X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2013-04-02
- NPI last updated
- 2024-03-21
- NPI record certified
- 2024-03-21
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 2351 Erwin Rd, Durham, NC, 27705 · 40 Temple St Ste 1b, New Haven, CT, 06510 · 203 Lothrop St, Pittsburgh, PA, 15213